Hypha Labs AAQS
The The AAQS of Hypha Labs (FUNI) as of Nov 5, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
4
YoY
0.00%
Last updated:
Hypha Labs has a current AAQS of 4.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Hypha Labs in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Hypha Labs in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Hypha Labs AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
4.00 USD
Jan 1, 2019
4.00 USD
Jan 1, 2020
4.00 USD
Jan 1, 2021
4.00 USD
Jan 1, 2022
4.00 USD
Jan 1, 2023
4.00 USD
Jan 1, 2024
4.00 USD
Jan 1, 2025
4.00 USD
| YEAR | AAQS | YoY |
|---|---|---|
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | 0.00% | |
| 4 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Hypha Labs Stock analysis
What does Hypha Labs do? Hypha Labs Inc operates through its subsidiary Digipath Labs, Inc., providing cannabis testing services using FDA-compliant equipment to detect contaminants like pesticides, heavy metals, and microbial toxins for growers, dispensaries, and producers. The company offers data analytics and education services alongside testing, targeting cannabis industry stakeholders including patients and end users. Its business model relies on third-party testing contracts from cannabis businesses and data analytics subscriptions, with revenue generated from laboratory services and educational content for industry professionals.
Digipath Labs screens medicinal and recreational cannabis for harmful contaminants including residual solvents, moisture, and aflatoxins, serving a range of clients from cultivators to dispensaries. The company's analytics and training services complement its core testing business, creating multiple revenue streams within the cannabis testing sector. Revenue is derived from testing fees, data analytics packages, and educational programs tailored to cannabis industry participants. Hypha Labs is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Hypha Labs stock
The AAQS of Hypha Labs is 4 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Hypha Labs since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Hypha Labs
All Key Metrics — Hypha Labs
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth